Sleep Apnea Treatment Startup Nexense Raises $3M, Partners With GE

February 2, 2015 | Israeli startup Nexense has raised $3 million at a valuation of $30 million for its snoring and sleep apnea treatment, which has already obtained CE marketing certification in Europe. The company says it has already sold 1,000 units of its product in Europe and Israel, and will use the new funding to develop the next generation of the product. Worn as a chest strap or wristwatch, the Nexense device monitors various physical parameters during sleep, and vibrates—without waking the sleeper—when it detects snoring or sleep apnea. The Ramat Gan-based company led by CEO Bary Molchadsky has already partnered with General Electric, which holds an 8% stake in the company.